Search results
Results from the WOW.Com Content Network
At the beginning of 2011, DePuy Orthopaedics said they were phasing out the ASR Hip Implant because of declining sales, but never mentioned the high failure rate data from an Australian implant registry. In March 2011, The New York Times reported that DePuy issued its first warning to doctors and patients about the high early failure rate.
Metallosis. Metallosis is the medical condition involving deposition and build-up of metal debris in the soft tissues of the body. [1] Metallosis has been known to occur when metallic components in medical implants, specifically joint replacements, abrade against one another. [1] Metallosis has also been observed in some patients either ...
On August 24, 2010, DePuy recalled all ASR hip implant systems sold since 2003. The 2010 DePuy Hip Recall was issued after research released by the National Joint Registry (NJR) found high rates of hip replacement failure for the ASR XL Acetabular and ASR Hip Resurfacing systems.
It is the latest in a series of recalls the New Brunswick, N.J., company has issued, ranging from over-the-counter medication to hip replacements from its subsidiary, DePuy Orthopaedics.
doc-071204
Johnson & Johnson (JNJ) has issued another recall, and this time, it's not over a typo. The company's Animas unit recalled five lots of leaking insulin cartridges that could lead to serious health ...
DePuy has 15 days to notify the FDA of the specific steps it has taken to correct the violations. It also wants an explanation of how the company plans to prevent these violations or similar ones ...
D019644. MedlinePlus. 002975. [ edit on Wikidata] Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, that is, a hip prosthesis. [1] Hip replacement surgery can be performed as a total replacement or a hemi/semi (half) replacement.